Portfolio company
Nanolyze AB
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops optical waveguide instruments for label-free nanoparticle analysis, providing researchers with tools to study nanomedicines and biological particles in real time.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
NANOLYZE
This company develops waveguide microscopy equipment for real-time analysis of nanoparticles to support researchers in drug development and nanomedicine.
Fida Biosystems
This company develops biophysical analysis platforms for characterising proteins and nanoparticles, serving researchers, biotechnology firms, and pharmaceutical manufacturers to accelerate drug development.
RNAnalytics
This company develops modular analysis toolkits and software for lipid nanoparticle characterisation to support biotech and pharmaceutical firms developing RNA-based therapies.
LUMICKS
This company develops single-molecule and cell avidity analysis instruments for academic researchers and pharmaceutical companies to study biological mechanisms and develop life-saving therapies.
Refeyn
This company develops mass photometry instruments for biopharmaceutical firms and academic researchers to measure the molecular mass of single particles in solution.
Palamedrix
This company develops DNA nanotechnology and biosensor platforms for multi-omic detection and proteomic analysis for biopharmaceutical and academic research markets.
Portal Biotech
The company develops nanopore-based instruments for single-molecule protein sequencing to serve researchers in drug discovery, diagnostics and biosecurity sectors.
Optics11 Life
This company develops fibre-optic nanoindentation and muscle contractility instruments for researchers in mechanobiology, drug development, and regenerative medicine.
